U.S. Markets closed
S&P Futures
3,837.75-8.25(-0.21%)Dow Futures
31,000.00-82.00(-0.26%)Nasdaq Futures
13,358.00-37.50(-0.28%)
Johnson & Johnson (JNJ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
161.73-0.65 (-0.40%)
At close: 4:00PM EST
161.90 +0.17 (0.11%)
After hours: 7:59PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 162.38 |
| Open | 161.32 |
| Bid | 161.85 x 800 |
| Ask | 162.20 x 800 |
| Day's Range | 160.06 - 162.48 |
| 52 Week Range | 109.16 - 164.14 |
| Volume | 6,814,703 |
| Avg. Volume | 7,448,106 |
| Market Cap | 425.761B |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | 25.43 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 4.04 (2.49%) |
| Ex-Dividend Date | Feb 22, 2021 |
| 1y Target Est | N/A |
- MarketWatch
FDA approves first long-acting HIV drug combination
U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with the AIDS virus.
- TheStreet.com
Johnson & Johnson Vaccine Data Almost Ready for Analysis: Fauci
J&J; coronavirus vaccine has enough vaccine-trial data to begin analysis soon, Anthony Fauci said, according to a media report.
- Barrons.com
Hungary Approves Russia’s Covid-19 Vaccine
Russia’s Covid-19 vaccine, called Sputnik V, received its first emergency approval in the European Union on Thursday.
© 2021 Verizon Media. All rights reserved.
